Radiation Therapy Oncology Group

Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment

Phase 2Recruiting2025130 people2 May 2025clinicaltrials.gov

NCT02768558

Phase 3Terminated201620 people11 May 2016clinicaltrials.gov

NCT02764593

Phase 1Completed201640 people6 May 2016clinicaltrials.gov

NCT02573324

CollaboratorPhase 3Completed2015691 people9 Oct 2015clinicaltrials.gov

NCT01993810

Phase 3Active, not recruiting2014330 people25 Nov 2013clinicaltrials.gov

NCT01953952

Phase 2Withdrawn20130 people1 Oct 2013clinicaltrials.gov

NCT01730937

Phase 3Completed2013193 people21 Nov 2012clinicaltrials.gov

NCT01730950

Phase 2Completed2012182 people21 Nov 2012clinicaltrials.gov

NCT01711658

Phase 2Completed2013142 people22 Oct 2012clinicaltrials.gov

NCT01672892

Phase 3Completed2012289 people27 Aug 2012clinicaltrials.gov

NCT01546987

Phase 3Completed2012239 people7 Mar 2012clinicaltrials.gov

NCT01302834

Phase 3Completed2011987 people24 Feb 2011clinicaltrials.gov

NCT01220583

Phase 2Active, not recruiting2011252 people14 Oct 2010clinicaltrials.gov

NCT01134861

Phase 3Completed1994610 people2 Jun 2010clinicaltrials.gov

NCT01062425

CollaboratorPhase 2Completed2010261 people4 Feb 2010clinicaltrials.gov

NCT01062399

Phase 1/2Completed2010279 people4 Feb 2010clinicaltrials.gov

NCT01005329

CollaboratorPhase 2Completed200934 people30 Oct 2009clinicaltrials.gov

NCT00980954

Phase 3Completed2009236 people21 Sept 2009clinicaltrials.gov

NCT00777491

Phase 2Completed200870 people22 Oct 2008clinicaltrials.gov

NCT00771641

Phase 3Completed1,113 people13 Oct 2008clinicaltrials.gov